SBRT trials for Non-Small-Cell Lung Cancer

All SBRT trials · All Non-Small-Cell Lung Cancer trials

Phase breakdown

Recruiting trials studying SBRT for Non-Small-Cell Lung Cancer

• BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
  NCT04933903 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
  NCT06718309 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
  NCT06686771 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 75 locations

Common questions

How many trials study SBRT for Non-Small-Cell Lung Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.